As BMP7 has already been shown to be a marker of tumor progression and metastases development in breast and esophageal cancers [25, 37], it is worth further exploring the potential of BMP7 as a marker of malignant behavior by analyzing additional malignant PCC cases for its expression. This evidence concerns the gene BMP7 and neoplasm.